Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases runs this route for exploratory clinical trials in its own disease areas.
The activity code is R61, which is the first half of a phased mechanism used here on its own — exploratory work meant to establish whether a full trial is worth running.
The title carries a hard condition: a clinical trial is required. A proposal bui…
Exploratory clinical trials in arthritis, musculoskeletal and skin diseases, under the R61 phased mechanism used on its own. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up